IASLC Studying Impact of COVID-19 on International Lung Cancer Clinical Trial Enrollment, Mitigation Strategies

Cancer Clinical Trial Compensation: Undue or Long Overdue?

Revised U.S. Food and Drug Administration Trial Eligibility Guidance: A Major Step Toward Transforming Lung Cancer Clinical Trials

Can We Use the Word ‘Cure’ for a Subset of Selected Patients With Advanced NSCLC?

Immune Checkpoint Inhibitors Have Led to Substantial Improvements in Lung Cancer but Are Still Not a ‘Cure’

In Brief for June 22, 2022

Journal of Thoracic Oncology Impact Factor Surpasses 20

Step It Up For Research!

Foundation Announces 2022 Young Investigator Grant Recipients

Workshops Offer Opportunities for Education, Networking Based on Shared Interests, Specialties

WCLC Chairs Welcome Opportunity to Gather Face-to-Face

Virtual Program Brings WCLC to Attendees Worldwide